CVS Group Plc (CVSG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CVS Group Plc (CVSG) has a cash flow conversion efficiency ratio of 0.145x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX43.80 Million ≈ $5.33K USD) by net assets (GBX301.70 Million ≈ $36.71K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CVSG net asset quality index to measure how much of total assets are equity-financed.
CVS Group Plc - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how CVS Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CVSG cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CVS Group Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CVS Group Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sambo Industrial
KQ:009620
|
-0.150x |
|
Progressive Impact Corporation Bhd
KLSE:7201
|
0.520x |
|
Episurf Medical AB (publ)
ST:EPIS-B
|
-0.244x |
|
Qyou Media Inc
V:QYOU
|
1.397x |
|
Kiora Pharmaceuticals Inc
NASDAQ:KPRX
|
-0.227x |
|
MITCON Consultancy & Engineering Services Limited
NSE:MITCON
|
0.147x |
|
Big Rock Brewery Inc.
TO:BR
|
-0.021x |
|
SL Private Equity
LSE:SLPE
|
-0.001x |
Annual Cash Flow Conversion Efficiency for CVS Group Plc (2005–2025)
The table below shows the annual cash flow conversion efficiency of CVS Group Plc from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of CVS Group Plc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX301.70 Million ≈ $36.71K |
GBX82.10 Million ≈ $9.99K |
0.272x | +4.56% |
| 2024-06-30 | GBX260.50 Million ≈ $31.70K |
GBX67.80 Million ≈ $8.25K |
0.260x | -20.84% |
| 2023-06-30 | GBX257.00 Million ≈ $31.27K |
GBX84.50 Million ≈ $10.28K |
0.329x | -5.32% |
| 2022-06-30 | GBX217.40 Million ≈ $26.45K |
GBX75.50 Million ≈ $9.19K |
0.347x | +10.24% |
| 2021-06-30 | GBX191.10 Million ≈ $23.25K |
GBX60.20 Million ≈ $7.32K |
0.315x | -32.37% |
| 2020-06-30 | GBX166.60 Million ≈ $20.27K |
GBX77.60 Million ≈ $9.44K |
0.466x | +83.50% |
| 2019-06-30 | GBX163.10 Million ≈ $19.84K |
GBX41.40 Million ≈ $5.04K |
0.254x | +7.03% |
| 2018-06-30 | GBX157.70 Million ≈ $19.19K |
GBX37.40 Million ≈ $4.55K |
0.237x | -29.73% |
| 2017-06-30 | GBX88.00 Million ≈ $10.71K |
GBX29.70 Million ≈ $3.61K |
0.338x | -43.63% |
| 2016-06-30 | GBX46.60 Million ≈ $5.67K |
GBX27.90 Million ≈ $3.39K |
0.599x | +25.86% |
| 2015-06-30 | GBX39.10 Million ≈ $4.76K |
GBX18.60 Million ≈ $2.26K |
0.476x | -12.69% |
| 2014-06-30 | GBX31.20 Million ≈ $3.80K |
GBX17.00 Million ≈ $2.07K |
0.545x | +0.44% |
| 2013-06-30 | GBX24.70 Million ≈ $3.01K |
GBX13.40 Million ≈ $1.63K |
0.543x | +3.11% |
| 2012-06-30 | GBX20.35 Million ≈ $2.48K |
GBX10.71 Million ≈ $1.30K |
0.526x | -40.00% |
| 2011-06-30 | GBX16.57 Million ≈ $2.02K |
GBX14.53 Million ≈ $1.77K |
0.877x | +20.52% |
| 2010-06-30 | GBX12.05 Million ≈ $1.47K |
GBX8.77 Million ≈ $1.07K |
0.728x | -96.11% |
| 2009-06-30 | GBX476.00K ≈ $57.92 |
GBX8.89 Million ≈ $1.08K |
18.685x | +846.52% |
| 2008-06-30 | GBX-1.20 Million ≈ $-145.40 |
GBX2.99 Million ≈ $363.92 |
-2.503x | +26.84% |
| 2007-06-30 | GBX-1.54 Million ≈ $-187.86 |
GBX5.28 Million ≈ $642.67 |
-3.421x | -30.13% |
| 2006-06-30 | GBX-1.02 Million ≈ $-123.62 |
GBX2.67 Million ≈ $324.98 |
-2.629x | -149.98% |
| 2005-06-30 | GBX-1.20 Million ≈ $-146.01 |
GBX1.26 Million ≈ $153.55 |
-1.052x | -- |
About CVS Group Plc
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail … Read more